P

Inventor

STADLWIESER JOSEF

CH14 patents
⚠️ This page may combine multiple inventors who share the name “STADLWIESER JOSEF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

6 patents
US5583222ADec 10, 1996

Azepanes and their ring homologues having protein kinase inhibiting activity

HOFFMANN LA ROCHE15 citations80
US5827883AOct 27, 1998

Dermatological use of vitamin D derivatives

HOFFMANN LA ROCHE15 citations73
US5750706AMay 12, 1998

Azepanes and their ring homologues having protein kinase inhibiting activity

HOFFMANN LA ROCHE7 citations72
US6136969AOct 24, 2000

Azepanes

HOFFMANN LA ROCHE2 citations62
US5907038AMay 25, 1999

Azepanes

HOFFMANN LA ROCHE2 citations62
US5914406AJun 22, 1999

Azepanes and their ring homologues having protein kinase inhibiting activity

HOFFMANN LA ROCHE1 citations50

STADLWIESER JOSEF

3 patents
US8927557B2Jan 6, 2015

Methylpyrrolopyrimidinecarboxamides

STADLWIESER JOSEF4 citations67
US8445501B2May 21, 2013

Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines

STADLWIESER JOSEF0 citations36
US8816085B2Aug 26, 2014

Methylpyrrolopyridinecarboxamides

STADLWIESER JOSEF0 citations35

ALTANA PHARMA AG

1 patent
US6818651B2Nov 16, 2004

(Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors

ALTANA PHARMA AG33 citations92

BAYER SCHERING PHARMA AG

1 patent
US7879853B2Feb 1, 2011

4,6-disubstituted pyrimidines and their use as protein kinase inhibitors

BAYER SCHERING PHARMA AG8 citations82

MAX PLANCK GES ZUR FORDRUNGDER

1 patent
US6489327B1Dec 3, 2002

Tryptase inhibitors

MAX PLANCK GES ZUR FORDRUNGDER8 citations64

MAX PLANCK GESELLSCHAFT

1 patent
US6613769B1Sep 2, 2003

Tryptase inhibitors

MAX PLANCK GESELLSCHAFT2 citations58

TAKEDA GMBH

1 patent
US9376442B2Jun 28, 2016

Methylpyrrolopyrimidinecarboxamides

TAKEDA GMBH0 citations48